Events & Presentations

Date	Event Details	Remind Me
Aug 5, 2021 4:30 PM EDT	Arrowhead Pharmaceuticals 2021 Third Quarter Results Listen to webcast	Add to Outlook Add to Google Calendar

Date	Event Details
Nov 12, 2018	The Liver Meeting® 2018, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD) Supporting Materials: AASLD 2018 ARO-AAT Poster 3 MB AASLD 2018 ARO-HBV Poster 654.3 KB View Additional Information First Results with RNA interference (RNAi) in Chronic Hepatitis B (CHB) Using ARO-HBV Publication Number: LB-25 Session: Late-Breaking Poster Session Session Date and Time: November 12, 2018 from 8:00 AM to 5:30 PM PT Location: Moscone Center North/South Building, Hall C Authors: Dr. Edward J. Gane, et al. A Phase 1 Single and Multiple Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Effect of ARO-AAT on Serum Alpha-1 Antitrypsin levels in Normal Adult Volunteers Publication Number: LB-9 Session: Late-Breaking Poster Session Session Date and Time: November 12, 2018 from 8:00 AM to 5:30 PM PT Location: Moscone Center North/South Building, Hall C Authors: Dr. Christian Schwabe, et al.
Nov 9, 2018	The Search for HBV / HDV Cure: Challenges for Industry Supporting Materials: View Presentation 11.7 MB Location: San Francisco View Additional Information November 9, 11:15 a.m. PST – Dr. Given will deliver an oral presentation titled, “AROHBV1001 Results Update”
Nov 7, 2018	International HBV Cure Workshop 2018 Supporting Materials: View Presentation 14.4 MB Location: Toronto View Additional Information November 7, 3:35 p.m. EST – Bruce Given, M.D., Arrowhead’s chief operating officer, will deliver an oral presentation titled, “Clinical update on reducing HBV virus and antigen production using RNAi”
Nov 6, 2018	BIT’s 16th Annual Congress of International Drug Discovery Science and Technology Supporting Materials: View Presentation 28.9 MB Location: Jinan, China View Additional Information November 6, 11:20 a.m. CST – Zhen Li, Ph.D., Arrowhead’s senior vice president of chemistry and non-clinical development, will deliver a keynote presentation titled, “Discovery and Development of Arrowhead Clinical Candidates ARO-AAT and ARO-HBV”
Oct 18, 2018 11:15 AM MDT	North American Cystic Fibrosis Conference Supporting Materials: View Presentation 1.7 MB Location: Denver, CO View Additional Information Erik Bush, Ph.D., Arrowhead’s director of extra-hepatic targeting, will deliver a poster presentation titled, “A novel targeted RNAi molecule (TRiM™) delivery platform for the therapeutic inhibition of ENaC in cystic fibrosis lung disease”
Oct 16, 2018 1:00 PM EDT	Arrowhead Analyst R&D Day 2018 Listen to webcast Supporting Materials: View Presentation 2.7 MB Location: New York, NY View Additional Information Arrowhead management and external key opinion leaders will discuss Arrowhead’s emerging pipeline of RNAi therapeutics
Oct 9, 2018 1:00 PM EDT	Chardan 2nd Annual Genetic Medicines Conference Listen to webcast Location: New York, NY View Additional Information Bruce Given, M.D., Arrowhead’s chief operating officer, will participate in a fireside chat.
Oct 5, 2018 7:00 AM EDT	2018 International HBV Meeting - The Molecular Biology of Hepatitis B Supporting Materials: View Presentation 4.3 MB Location: Taormina, Italy View Additional Information October 5, 1:00 p.m. CEST –Christine Wooddell, Ph.D., Arrowhead’s director of liver targeting, will deliver a poster presentation titled, “Gene expression analysis during and after RNAi treatment of chronically HBV infected chimpanzees”
Oct 4, 2018 8:30 AM EDT	Arrowhead/Janssen Collaboration Call Listen to webcast Supporting Materials: View Transcript 137.5 KB
Oct 2, 2018 10:55 AM EDT	2018 Cantor Fitzgerald Global Healthcare Conference Listen to webcast Supporting Materials: View Presentation 7.3 MB Location: New York, NY View Additional Information Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will deliver a corporate presentation